These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3302392)

  • 1. [FFDP (fibrin fibrinogen degradation products), D-dimers, and SFMC (soluble fibrin monomer complex)].
    Kuroso K
    Rinsho Byori; 1987 Apr; Spec No 70():224-32. PubMed ID: 3302392
    [No Abstract]   [Full Text] [Related]  

  • 2. [Soluble fibrin monomer complex (SFMC), soluble fibrin monomer (SFM)].
    Kawai Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():600-3. PubMed ID: 15658400
    [No Abstract]   [Full Text] [Related]  

  • 3. [Soluble fibrin monomer complex (SFMC)].
    Kazama M; Miyajima Y; Wakasugi K
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():22-5. PubMed ID: 8753171
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relationship between the plasma levels of soluble fibrin monomer and the formation of soluble fibrin monomer complex (SFMC)].
    Okajima K; Okabe H; Kumagai T; Yang WP; Maeda M; Miyagawa S; Watanabe E; Yoshimi K; Koga S; Takatsuki K
    Rinsho Byori; 1989 Apr; 37(4):411-5. PubMed ID: 2787429
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrin monomer complexes (SFMC) after substitution of antithrombin III (AT III) in consumption coagulopathy.
    Töpfer G; Ehrhardt W; Dornheim G; Seifert A; Schmidt LH; Senger C; Funke U; Schulze M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):581-5. PubMed ID: 2465977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggristin (ristomycin) precipitation test: a new tool for the detection of fibrin monomer and fibrin degradation products.
    Pfliegler G; Vogel G; Boda Z; Zajka G; Rak K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):629-35. PubMed ID: 2414192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of soluble fibrin monomer complex analysis in blood coagulation and fibrinolysis tests].
    Tanaka A; Fujimaki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():906-9. PubMed ID: 2622027
    [No Abstract]   [Full Text] [Related]  

  • 10. [SF/SFMC].
    Koga S
    Rinsho Byori; 2011 Feb; Suppl 147():71-8. PubMed ID: 21761752
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical implications of analyses of fibrinogen and fibrin-derivatives in DIC].
    Magari Y; Ito M; Itoga T
    Rinsho Ketsueki; 1986 Oct; 27(10):1992-2007. PubMed ID: 3820619
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid estimation of soluble fibrin monomer complexes by high performance liquid chromatography for the purpose of early detection of DIC.
    Ishikawa A; Iwasaki Y
    Thromb Res; 1983 Jun; 30(5):521-6. PubMed ID: 6612682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrin and fibrinogen degradation products].
    Mitsuhashi H; Kinouchi T
    Nihon Rinsho; 1999 Sep; 57 Suppl():566-8. PubMed ID: 10543179
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
    Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrin/fibrinogen degradation products in diseases of the respiratory organs (a review of the literature)].
    Bodaretskiĭ GM; Bodaretskaia OI; Shekhter IE; Riabkova NV; Ena IaM
    Vrach Delo; 1990 May; (5):60-4. PubMed ID: 2204201
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quantitative evaluation of fibrinogen-fibrin degradation products (FDP) in the blood of full-term newborn infants, using the staphylococcal clumping test].
    Schettini F; Altomare M; Mautone A
    Boll Soc Ital Biol Sper; 1976 Feb; 52(3):121-6. PubMed ID: 949391
    [No Abstract]   [Full Text] [Related]  

  • 19. Disseminated intravascular coagulation and a negative D-dimer test.
    Constantinescu AA; Berendes PB; Levin MD
    Neth J Med; 2007 Nov; 65(10):398-400. PubMed ID: 18057464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrin/fibrinogen degradation products (FDP)].
    Kuroso K; Fujimaki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():892-5. PubMed ID: 2622025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.